Faggiano T, Yin J, Patel N, Karim A, et al. Predictors of discontinuing injectable cabotegravir/rilpivirine and virologic outcomes after resuming oral antiretroviral therapy. HIV Med 2025 Oct 12. doi: 10.1111/hiv.70128.
PMID: 41077802